DrugPatentWatch Database Preview
Belatacept - Biologic Drug Details
Try a free trial
See Plans and Pricing
Summary for belatacept
| Tradenames: | 1 |
| Patents: | 17 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for belatacept
| Mechanism of Action | CD80-directed Antibody Interactions CD86-directed Antibody Interactions |
| Physiological Effect | T Lymphocyte Costimulation Activity Blockade |
US Patents for belatacept
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | Excision BioTherapeutics, Inc. (Bedminster, unknown) Temple University of the Commonwealth System of Higher Education (Philadelphia, unknown) | 2039-05-17 | RX | search | |
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | Icahn School of Medicine at Mount Sinai (New York, NY) | 2034-06-26 | RX | search | |
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | ChemoCentryx, Inc. (Mountain View, CA) | 2036-04-04 | RX | search | |
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | Perle Bioscience, Inc. (Atlanta, GA) | 2032-09-27 | RX | search | |
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | Bristol-Myers Squibb Company (Princeton, NJ) Domantis Limited (Brentford, Middlesex, GB) | 2031-10-13 | RX | search | |
| Bristol Myers Squibb | NULOJIX | belatacept | INJECTABLE; INJECTION | 125288 | 001 | 2011-06-15 | ➤ Sign Up | Momenta Pharmaceuticals, Inc. (Cambridge, MA) | 2036-04-30 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for belatacept
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2851814 | ➤ Sign Up |
| New Zealand | 624772 | ➤ Sign Up |
| Canada | 2953368 | ➤ Sign Up |
| Japan | 2012526853 | ➤ Sign Up |
| Australia | 2012229236 | ➤ Sign Up |
| Australia | 2013323462 | ➤ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for belatacept
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 11/036 | Ireland | ➤ Sign Up | PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617 |
| 00509 | Netherlands | ➤ Sign Up | PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001 - 002 20110617 |
| C/GB11/061 | United Kingdom | ➤ Sign Up | PRODUCT NAME: BELATACEPT; REGISTERED: UK EU/1/11/694/001 20110617; UK EU/1/11/694/002 20110617 |
| 2011100063 | Germany | ➤ Sign Up | PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617 |
| C0053 | France | ➤ Sign Up | PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617 |
| 2011014 | Lithuania | ➤ Sign Up | PRODUCT NAME: BELATACEPTUM; REGISTRATION NO/DATE: EU/1/11/694/001, 2011 06 17 EU/1/11/694/002 20110617 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
